Tumor inhibiting tetrapeptide bearing modified phenethyl amides
AssigneeArizona Board of Regents acting on behalf of Arizona State University
InventorsGeorge R. Pettit, Jozsef Barkoczy
Life of this patent
Estimating the term…
Abstract
New tetrapeptides bearing modified phenethyl amides are elucidated and syesized and found to exhibit tumor inhibiting effects when measured against the NCI screen for six major types of human cancer and against the murine P388 lymphocytic cell line. The new modified tetrapeptides phenethyl amides are 6(a-k).
Claims8
A compound having the following structural formula ##STR5## wherein R.sup.1 is selected from the group consisting of OCH.sub.3, NO.sub.2, F, Cl, Br, and H;
- R.sup.2 is selected from the group consisting of OCH.sub.3, H, and Cl;
- and R.sup.3 is selected from the group consisting of H and Cl, provided that if R.sup.1 is NO.sub.2, Cl, F, or Br, R.sup.2 =R.sup.3 =H;
- that if R.sup.2 =Cl then R.sup.1 =R.sup.3 =H;
- that if R.sup.3 =Cl then R.sup.2 =R.sup.3 =H and that if R.sup.1 =OCH.sub.3, then R.sup.2 =R.sup.1 and R.sup.3 =H.
A compound having the following structural formula ##STR6## wherein R.sup.4 is selected from the group consisting of H and CH.sub.3, R.sup.5 is selected from the group consisting of H and CH.sub.3, R.sup.6 is selected from the group consisting of CH.sub.3 and H, R.sup.7 is selected from the group consisting of H and OH, and R.sup.8 is selected from the group consisting of H and OH;
- provided that either R.sup.7 or R.sup.8 =OH, that at least one of R.sup.4, R.sup.5 and R.sup.6 =CH.sub.3 and that at least two of R.sup.4, R.sup.5, R.sup.6, R.sup..differential. and R.sup.8 =H.
A method of inhibiting the growth of cancer cells selected from the group of cell lines consisting of P388, OVCAR-3, SF295, A498, NCI-460, KM20L2 and SK-MEL-3, comprising of engaging said selected cell with a cell growth inhibitory amount of the compound having the following structural formula:
- ##STR7## wherein R.sup.1 is selected from the group consisting of OCH.sub.3, NO.sub.2, F, Cl, Br, and H;
- R.sup.2 is selected from the group consisting of OCH.sub.3, H, and Cl;
- and R.sup.3 is selected from the group consisting of H and Cl, provided that if R.sup.1 is NO.sub.2, Cl, F, or Br, R.sup.2 =R.sup.3 =H;
- that if R.sup.2 =Cl then R.sup.1 =R.sup.3 =H;
- that if R.sup.3 =Cl then R=R.sup.2 =H and that if R.sup.1 =OCH.sub.3, then R.sup.2 =R.sup.1 and R.sup.3 =H.
A method of inhibiting the growth of cancer cells selected from the group of cell lines consisting of P388, OVCAR-3, SF295, A498, NCI-460, KM20L2 and SK-MEL-3, comprising of engaging said cell line with a cell growth inhibitory amount of the compound having the following structural formula:
- ##STR8## wherein R.sup.4 is selected from the group consisting of H and CH.sub.3, R.sup.5 is selected from the group consisting of H and CH.sub.3, R.sup.6 is selected from the group consisting of CH.sub.3 and H, R.sup.7 is selected from the group consisting of H and OH, and R.sup.8 is selected from the group consisting of H and OH;
- provided that either R.sup.7 of R.sup.8 =OH, that at least one of R.sup.4, R.sup.5 and R.sup.6 =CH.sub.3 and that at least two of R.sup.4, R.sup.5, R.sup.6, R.sup.7 and R.sup.8 =H.
Dependencies are inferred from the claim text.